Doug Wilson

Doug Wilson

Directeur Technique/Scientifique/R&D chez
Ferghana Partners Group
89 ans
Health Technology
Finance
Consumer Non-Durables

Profil

Douglas John Wilson is currently the Director at Vaxxit SRL, Mainz Consulting Ltd., and the Chief Medical Officer at Ferghana Partners Group.
He previously served as Chairman at SeaDragon Ltd. from 2012 to 2015, Chairman at Adherium (NZ) Ltd., Non-Executive Chairman at Adherium Ltd., and Non-Independent Executive Director at Neuren Pharmaceuticals Ltd. from 2011 to 2012.
He also served as Non-Executive Director at PYC Therapeutics Ltd. from 2007 to 2016 and as Independent Non-Executive Director at Photonz Corp.
Ltd. from 2011 to 2013.
Additionally, he is currently serving as an Independent Non-Executive Director at AFT Pharmaceuticals Ltd. since 2012.
He previously worked as Senior Vice President-Medical & Regulatory Affairs at Boehringer Ingelheim Pharmaceuticals, Inc. He holds a doctorate degree from the University of London.

Postes actifs de Doug Wilson

SociétésPosteDébut
Directeur/Membre du Conseil -
Mainz Consulting Ltd.
Directeur/Membre du Conseil -
Directeur Technique/Scientifique/R&D -

Anciens postes connus de Doug Wilson

SociétésPosteFin
AFT PHARMACEUTICALS LIMITED Directeur/Membre du Conseil 05/08/2022
PYC THERAPEUTICS LIMITED Président 08/10/2015
SEADRAGON LIMITED Président 04/05/2015
ADHERIUM LIMITED Président 01/09/2016
Directeur Technique/Scientifique/R&D -
Voir l'expérience en détail de Doug Wilson

Formation de Doug Wilson

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

27

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Health Technology

Finance

Consumer Non-Durables

Consumer Services

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Mainz Consulting Ltd.

  1. Bourse
  2. Insiders
  3. Doug Wilson